239 related articles for article (PubMed ID: 31751333)
21. Single Versus Double Dose Praziquantel Comparison on Efficacy and Schistosoma mansoni Re-Infection in Preschool-Age Children in Uganda: A Randomized Controlled Trial.
Nalugwa A; Nuwaha F; Tukahebwa EM; Olsen A
PLoS Negl Trop Dis; 2015 May; 9(5):e0003796. PubMed ID: 26011733
[TBL] [Abstract][Full Text] [Related]
22. Re-assessment of schistosomiasis in nine endemic districts with cluster sampling in Sierra Leone.
Kargbo-Labour I; Redwood-Sawyerr V; Conteh A; Chop E; Bah MS; Koroma A; Kabia U; Klein L; Juneja S; Houck P; Reid S; Evans D; Weaver AM; Phillips AE; Zhang Y
Front Public Health; 2024; 12():1415486. PubMed ID: 38932788
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of two praziquantel treatments among primary school children in an area of high Schistosoma mansoni endemicity, Nile Delta, Egypt.
Barakat R; El Morshedy H
Parasitology; 2011 Apr; 138(4):440-6. PubMed ID: 21078223
[TBL] [Abstract][Full Text] [Related]
24. Effects of Schistosoma mansoni and praziquantel treatment on the lower gastrointestinal mucosa: A cohort study in Tanzania.
Pham K; Mtalitinya GS; Aristide C; Airewele EA; Nyakaru DK; McMahon P; Mulaki GM; Corstjens PLAM; J de Dood C; van Dam GJ; Changalucha JM; Mazigo HD; Lee MH; Jaka H; Downs JA
Acta Trop; 2023 Feb; 238():106752. PubMed ID: 36410422
[TBL] [Abstract][Full Text] [Related]
25. Praziquantel Treatment of
Nono JK; Mpotje T; Mosala P; Aziz NA; Musaigwa F; Hlaka L; Spangenberg T; Brombacher F
Front Immunol; 2021; 12():748387. PubMed ID: 34956183
[TBL] [Abstract][Full Text] [Related]
26. Six rounds of annual praziquantel treatment during a national helminth control program significantly reduced schistosome infection and morbidity levels in a cohort of schoolchildren in Zimbabwe.
Mduluza T; Jones C; Osakunor DNM; Lim R; Kuebel JK; Phiri I; Manangazira P; Tagwireyi P; Mutapi F
PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008388. PubMed ID: 32569278
[TBL] [Abstract][Full Text] [Related]
27. Comparing the performance of circulating cathodic antigen and Kato-Katz techniques in evaluating Schistosoma mansoni infection in areas with low prevalence in selected counties of Kenya: a cross-sectional study.
Okoyo C; Simiyu E; Njenga SM; Mwandawiro C
BMC Public Health; 2018 Apr; 18(1):478. PubMed ID: 29642875
[TBL] [Abstract][Full Text] [Related]
28. SCHISTOACT: a protocol for an open-label, five-arm, non-inferiority, individually randomized controlled trial of the efficacy and safety of praziquantel plus artemisinin-based combinations in the treatment of Schistosoma mansoni infection.
Obonyo CO; Were VO; Wamae P; Muok EMO
Trials; 2023 Nov; 24(1):763. PubMed ID: 38012787
[TBL] [Abstract][Full Text] [Related]
29. Effect of praziquantel treatment of Schistosoma mansoni during pregnancy on immune responses to schistosome antigens among the offspring: results of a randomised, placebo-controlled trial.
Tweyongyere R; Mawa PA; Kihembo M; Jones FM; Webb EL; Cose S; Dunne DW; Vennervald BJ; Elliott AM
BMC Infect Dis; 2011 Sep; 11():234. PubMed ID: 21888656
[TBL] [Abstract][Full Text] [Related]
30. A new focus of schistosomiasis mansoni in Hayk town, northeastern Ethiopia.
Amsalu G; Mekonnen Z; Erko B
BMC Res Notes; 2015 Feb; 8():22. PubMed ID: 25643852
[TBL] [Abstract][Full Text] [Related]
31. Performance and safety of praziquantel for treatment of intestinal schistosomiasis in infants and preschool children.
Sousa-Figueiredo JC; Betson M; Atuhaire A; Arinaitwe M; Navaratnam AM; Kabatereine NB; Bickle Q; Stothard JR
PLoS Negl Trop Dis; 2012; 6(10):e1864. PubMed ID: 23094120
[TBL] [Abstract][Full Text] [Related]
32. The Efficacy of Single-Dose versus Double-Dose Praziquantel Treatments on
Munisi DZ; Buza J; Mpolya EA; Angelo T; Kinung'hi SM
Biomed Res Int; 2017; 2017():7035025. PubMed ID: 29094048
[TBL] [Abstract][Full Text] [Related]
33. Accuracy of urine circulating cathodic antigen test for the diagnosis of Schistosoma mansoni in preschool-aged children before and after treatment.
Coulibaly JT; N'Gbesso YK; Knopp S; N'Guessan NA; Silué KD; van Dam GJ; N'Goran EK; Utzinger J
PLoS Negl Trop Dis; 2013; 7(3):e2109. PubMed ID: 23556011
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial.
Barda B; Coulibaly JT; Puchkov M; Huwyler J; Hattendorf J; Keiser J
PLoS Negl Trop Dis; 2016 Sep; 10(9):e0005008. PubMed ID: 27636542
[TBL] [Abstract][Full Text] [Related]
35. High levels of Schistosoma mansoni infections among schoolchildren in central Sudan one year after treatment with praziquantel.
Ahmed AM; El Tash LA; Mohamed EY; Adam I
J Helminthol; 2012 Jun; 86(2):228-32. PubMed ID: 21729382
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of Praziquantel Treatment and
Berhanu MS; Atnafie SA; Ali TE; Chekol AA; Kebede HB
Ethiop J Health Sci; 2022 May; 32(3):631-640. PubMed ID: 35813666
[TBL] [Abstract][Full Text] [Related]
37. Evaluating a point-of-care circulating cathodic antigen test (POC-CCA) to detect Schistosoma mansoni infections in a low endemic area in north-eastern Brazil.
Bezerra FSM; Leal JKF; Sousa MS; Pinheiro MCC; Ramos AN; Silva-Moraes V; Katz N
Acta Trop; 2018 Jun; 182():264-270. PubMed ID: 29526480
[TBL] [Abstract][Full Text] [Related]
38. Impact of two rounds of praziquantel mass drug administration on Schistosoma mansoni infection prevalence and intensity: a comparison between community wide treatment and school based treatment in western Kenya.
Onkanga IO; Mwinzi PN; Muchiri G; Andiego K; Omedo M; Karanja DM; Wiegand RE; Secor WE; Montgomery SP
Int J Parasitol; 2016 Jun; 46(7):439-45. PubMed ID: 26940547
[TBL] [Abstract][Full Text] [Related]
39. Repeated praziquantel treatments remodel the genetic and spatial landscape of schistosomiasis risk and transmission.
Barbosa LM; Reis EA; Dos Santos CR; Costa JM; Carmo TM; Aminu PT; Pitanga TN; Ponce-Terashima R; Blank WA; Silva LK; Reis MG; Blanton RE
Int J Parasitol; 2016 May; 46(5-6):343-50. PubMed ID: 26953255
[TBL] [Abstract][Full Text] [Related]
40. Impact of Four Years of Annual Mass Drug Administration on Prevalence and Intensity of Schistosomiasis among Primary and High School Children in Western Kenya: A Repeated Cross-Sectional Study.
Abudho BO; Ndombi EM; Guya B; Carter JM; Riner DK; Kittur N; Karanja DMS; Secor WE; Colley DG
Am J Trop Med Hyg; 2018 May; 98(5):1397-1402. PubMed ID: 29532768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
